Novartis India Limited (BOM:500672)
India · Delayed Price · Currency is INR 1,637.10
+22.15 (1.37%)
At close: Sep 4, 2026
Novartis India Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Operating Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Net Income | 931.8 | 1,009 | 851.9 | 1,034 | -37.2 |
Depreciation & Amortization | 19.5 | 21.9 | 26.1 | 60.6 | 96.5 |
Loss (Gain) From Sale of Assets | 0.3 | -1.1 | -32.1 | -28.9 | 1.4 |
Stock-Based Compensation | 2.7 | 3.3 | 2.5 | 3.8 | 18.5 |
Provision & Write-off of Bad Debts | -1.3 | -1.7 | 1.7 | 3.7 | -3.6 |
Other Operating Activities | -346.6 | -278.1 | 193.5 | -384.8 | -356.1 |
Change in Accounts Receivable | 32.2 | 15 | -53.4 | 80.3 | -42 |
Change in Inventory | -122.1 | 37.5 | 98.6 | 23.5 | -91.2 |
Change in Accounts Payable | 21.8 | -92.5 | 21.2 | -100.2 | 148.3 |
Change in Other Net Operating Assets | -71 | 32.4 | 24 | -243.6 | 652.1 |
Operating Cash Flow | 467.3 | 745.7 | 1,134 | 448 | 386.7 |
Operating Cash Flow Growth | -37.33% | -34.24% | 153.13% | 15.85% | - |
Investing Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Capital Expenditures | -3.4 | - | - | -3.1 | -5 |
Sale of Property, Plant & Equipment | 0.2 | 3.2 | 32.7 | 39.4 | - |
Investment in Securities | -200.2 | -449 | -48.3 | -1,769 | 720 |
Other Investing Activities | 379.7 | 412.7 | 346.9 | 199.8 | 155.4 |
Investing Cash Flow | 176.3 | -33.1 | 331.3 | -1,533 | 870.4 |
Financing Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Long-Term Debt Repaid | -22 | -24.1 | -37 | -57.4 | -109 |
Lease Payments | -22 | -24.1 | -37 | -57.4 | -109 |
Net Debt Issued (Repaid) | -22 | -24.1 | -37 | -57.4 | -109 |
Common Dividends Paid | -617.3 | -617.3 | -1,173 | -246.9 | -246.9 |
Other Financing Activities | - | -0.1 | -0.1 | -0.5 | -0.4 |
Financing Cash Flow | -639.3 | -641.5 | -1,210 | -304.8 | -356.3 |
Net Cash Flow
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Net Cash Flow | 4.3 | 71.1 | 255.4 | -1,389 | 900.8 |
Free Cash Flow
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | 463.9 | 745.7 | 1,134 | 444.9 | 381.7 |
Free Cash Flow Growth | -37.79% | -34.24% | 154.89% | 16.56% | - |
Free Cash Flow Margin | 13.09% | 20.93% | 33.84% | 11.75% | 9.55% |
Free Cash Flow Per Share | 18.79 | 30.20 | 45.93 | 18.02 | 15.46 |
Levered Free Cash Flow | 700.16 | 484.19 | 498.14 | 568.16 | 1,205 |
Unlevered Free Cash Flow | 708.04 | 489 | 507.45 | 579.1 | 1,236 |
Free Cash Flow After Leases | 441.9 | 721.6 | 1,097 | 387.5 | 272.7 |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash Interest Paid | - | 0.1 | 0.1 | 0.5 | 0.4 |
Cash Income Tax Paid | 352.6 | 162.9 | -382.7 | -23.4 | 185.9 |
Change in Working Capital | -139.1 | -7.6 | 90.4 | -240 | 667.2 |